Electra Secures 100% of Cobalt Feedstock Required for Refinery Commissioning and Ramp-Up
Extended Glencore agreement provides long-term feedstock supply through 2031 as Electra advances toward mechanical completion in 2027 TORONTO,…
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has…
The United Kingdom asks FIFA to investigate Argentina for the Falklands banner
You might be interested in Possible betrayal of Raphinha: his father would have swindled him out of a…
GasHub Completes LNG Facility for Rolls-Royce Seletar Campus and Commences LNG Supply and Operations
SINGAPORE, July 6, 2026 /PRNewswire/ — H2G Green Limited (“H2G”), through its 52.03%-owned subsidiary Gashubunited Utility Private Limited (“GasHub”),…
Heat wave: UK sets new June temperature record for third day in a row
It has warned of “population-wide adverse health effects” as doctors, teachers and climate experts cautioned that the UK…
Britain must prepare for scorching new normal
The “red alerts” issued by the Meteorological Office are rare, serious, and speak just as much to the…
Vanguard Announces Cash Distributions for the Vanguard ETFs
(VBU, VBG, VGAB, VAB, VSB, VSC, VCB, VGV, VLB, VRIF, VBAL, VCNS, VCIP, VGRO and VVSG) TORONTO, June…
Vanguard Announces Cash Distributions for the Vanguard ETFs
(VXC, VFV, VSP, VGG, VGH, VUN & VUS) TORONTO, June 19, 2026 (GLOBE NEWSWIRE) — Vanguard Investments Canada…
The most famous cat in the United Kingdom is already waiting for a new owner at Downing Street
LondonThe UK’s most famous cat is waiting for a new owner. Larry, adopted by the Prime Minister’s office…
Grid connections OKd for Negros solar projects
THE Energy Regulatory Commission (ERC) has recently approved the applications of Citicore Solar Negros Occidental 2 Inc. and…
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Company remains on track for a planned December 2026 evaluation of the clinical trial’s primary endpoint OCALA, Fla.,…
Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression
Collaboration leverages Engitix’s human ECM Platform to identify high-confidence targets for liver fibrosis regression LONDON, June 08, 2026…